Revenue - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Corcept Therapeutics Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Revenue
$569.6m
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
42%
Johnson & Johnson
NYSE:JNJ
Revenue
$86.6B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$46.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.6B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$62.5B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Revenue
$38.9B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
6%

See Also

What is Corcept Therapeutics Inc's Revenue?
Revenue
569.6m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Revenue amounts to 569.6m USD.

What is Corcept Therapeutics Inc's Revenue growth rate?
Revenue CAGR 10Y
42%

Over the last year, the Revenue growth was 33%. The average annual Revenue growth rates for Corcept Therapeutics Inc have been 18% over the past three years , 16% over the past five years , and 42% over the past ten years .

Back to Top